MAPT and Mental deterioration: Second, 18F‐AV‐1451 was closely associated with neurodegeneration and cognitive decline, while CSF tau biomarkers were only mildly associated with neurodegeneration, and not with cognition (when adjusted for diagnosis and other confounders).